COVID-19: Brazil adapts its regulatory environment in reaction to the virus outbreak

The Brazilian government has announced a set of measures to adjust its regulatory framework to the context of the Coronavirus (COVID-19).


The Brazilian National Institute of Metrology, Standardization and Industrial Quality (INMETRO) and the Brazilian Health Regulatory Agency (ANVISA) have sent five notifications to the WTO informing about the adaptation of its national regulatory framework in an intent to combat the current coronavirus crisis. Additionally, ANVISA has issued further orientation about the priority given on the analysis of Certificate of Good Manufacturing Practices (CBPF) processes and on the preferential access to products needed for in vitro diagnosis of the coronavirus. In addition, INMETRO has also made significant regulatory changes regarding medical devices. These changes include:



These are part of a series of strategic actions adopted by the Brazilian government aiming to enable rapid and large-volume access to products that can be used to cope with the coronavirus pandemic.



Go back